FACILITIES & CERTIFICATIONS
A global manufacturing platform built for quality, scale, and continuity.
FROM STRONG FOUNDATIONS TO A GLOBAL PRESENCE
Headquartered in Chennai, India, Softgel Healthcare operates as part of the Madras Group, one of India’s leading healthcare manufacturing platforms with more than 40 years of industry legacy.
Across the group, eight state-of-the-art manufacturing sites and more than 3,000 professionals support a full spectrum of dosage forms. Within this ecosystem, Softgel Healthcare serves as the group’s dedicated softgel specialist.
With over 20 years of experience, more than 300 stable formulations developed, and annual production exceeding 2 billion capsules, Softgel Healthcare combines scale with precision to support global pharmaceutical and nutraceutical partners.
Our long-term growth is further reinforced by the backing of Everstone Capital, enabling continued investment in capacity, technology, and geographic expansion.
BUILT ON SCIENCE. SCALED FOR GLOBAL IMPACT
Expanding global presence with a strong U.S. footprint
Current Manufacturing Facilities
Chennai, India
Softgel Healthcare’s primary manufacturing operations are based in Chennai, India, where advanced technology, skilled teams, and rigorous quality systems come together to deliver high-quality softgel solutions at scale.
High-speed servo-controlled softgel lines
Automated visual inspection systems
Capsule sizes from 0.25 mcg to 1500 mg
Multiple shapes, colors, coatings, and shell options
Laser and ink printing for product customization
Dedicated high-potent manufacturing line (hormones & oncology)
Sterilization-ready packaging aligned with USFDA and EU norms
New & Extended Manufacturing Facility
Built for scale, continuity, and long-term partnerships.
As part of its next phase of growth, Softgel Healthcare is investing in a new, extended manufacturing facility designed to expand capacity, enhance technological capabilities, and support increasing global demand.
This upcoming site will enable a dual-source manufacturing strategy, strengthening supply continuity and mitigating risk for global partners, while supporting higher production volumes and future dosage innovations.
Expanding Reach in the Americas
Softgel Healthcare is actively expanding its presence in the Americas to be closer to customers and more aligned with regional markets.
For partners across North and Latin America, this expansion delivers:
Direct access to expertise across development, regulatory, and scale-up
Time-zone alignment for faster collaboration
Improved responsiveness and support for local product launches
This regional presence reinforces Softgel Healthcare’s commitment to serving as a true CDMO partner, not only a manufacturer.
From Development to Distribution
The Prodose Advantage
Softgel Healthcare’s global platform is strengthened by Prodose, its fully owned U.S. subsidiary specializing in OTC and nutraceutical packaging and distribution.
Headquartered in Ronkonkoma, New York, Prodose operates a 106,000 sq. ft. facility with 13 high-speed packaging lines, supporting softgels, tablets, gummies, probiotics, and more.
Together, Softgel Healthcare and Prodose provide an end-to-end solution, from formulation and large-scale manufacturing in India to compliant, market-ready packaging and direct distribution in the United States.
Formulation
Manufacturing
Packaging
Distribution
Trust and Quality at Scale
Quality is not a claim, it is a measurable reality.
